Fluorescent probes detect hNQO1 in cancer cells, suggesting potential for better biomarker identification.
Fluorescent probes for single analyte might produce "false-positive" signals because the levels of the biomarkers could be up-regulated by some external factors such as drug stimulation, hypoxia, radiation, etc. Tumor-targeted...
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: